Recent Auxmin and PSMA scans show that my husband has BCR oligometastesis (MRI shows nothing). It seems there are two different treatment options/opinions:
1. Lupron OR Eligard OR Firmagon OR Orgovyx for a few months and then radiation, then continue hormone therapy for 1-1.5 years
2. Lupron OR Eligard + Zytiga for a few months and then radiation, then continue hormone therapy
There seems to be indication that Zytiga causes early hormone resistance. We are a bit concerned.
What's your experience/thoughts on what hormone therapy to take? If it's a combination of Lupron + Zytiga, do you take them simultaneously or do you take Lupron for 1 or 2 months or 3 months and then add Zytiga? What dosage each?
My husband's medical background:
Diagnosed in Dec 2019, Gleason 7 (3+4), PSA 4.5, CT scan: Clear, Bone scan: Clear. 3T MRI showed ECE. Had 6-week proton therapy in June/July 2020. No hormone therapy. PSA went up in March 2022 and did Auxmin and PSMA scans. He has a stent in his heart.
Thanks very much.
Written by
TCMG
To view profiles and participate in discussions please or .
Hi TCMG and spouse. Where exactly were the oligometastasis sites and how many? If they are lymph node only and located within the pelvis and none beyond, the he should definitely seek attempted curative therapy with IMRT radiation treatments (NOT protons beam) to the entire extended pelvic lymph node fields. With boost dosage targeting the identified nodes. This would be accompanied by ADT for a short term, probably 18-24 months. His choice for ADT should be Firmagon (Degarelix) or oral Orgivox, as these have less cardiovascular risk than the others.
Zytiga + p is a fine AAR drug to add if it is felt needed. It would be my first choice over Xtandi etc. but it may not be necessary for the adjuvant ADT to the pelvic RT described above. However, if there is metastasis beyond the pelvis then adding an AAR drug is important. On that case whether to target the oligomets with SBRT will need to be carefully considered with a good radiation oncologist. My own bias is to go after them if it can be done with reasonable safety.
Thanks for your reply. There are 5 areas of disease that show up in PSMA scan. See detailed findings below. One uptake in prostate, two lymph nodes in pelvic and one cluster slightly above pelvis I think (but RO seems to regard it as if it's in pelvis and is able to target it), one in 6th rib (One RO think it's mets but another RO is not sure).
FINDINGS:
PROSTATE/PROSTATE BED EVALUATION:
Focal uptake in the posterior prostate gland at the apex with max SUV 6.3 (axial 312).
LYMPH NODE EVALUATION:
Multiple prominent PSMA avid retroperitoneal/iliac chain nodes are stable to mildly increased in size compared to prior Axumin PET. For example:
-1.2 x 1.1 cm right common iliac chain node with max SUV 14.4, previously 0.9 x 0.9 cm (axial 264).
-0.9 x 0.6 cm left internal iliac chain node with max SUV 8.9, previously 0.9 x 0.5 cm (axial 268).
-5 mm right distal retroperitoneal retrocaval node with max SUV 5.9 (axial 247).
OSSEOUS STRUCTURES EVALUATION:
Redemonstrated right lateral sixth rib groundglass/sclerotic lesion with focal PSMA avidity of max SUV 4.2 (axial 150).
No additional suspicious lytic or sclerotic osseous lesions.
OTHER VISCERAL FINDINGS:
Head and neck:
Physiologic uptake in the salivary and lacrimal glands.
Thorax:
Unchanged medial left lower lobe tissue/atelectasis with background uptake.
There are no suspicious pulmonary nodules.
No foci of abnormal uptake or pathologically enlarged mediastinal, hilar, or axillary lymphadenopathy.
Gynecomastia is incidentally noted.
Abdomen and pelvis:
Physiologic uptake in the liver, spleen, and bowel.
Physiologic radiotracer clearance is seen in the urinary system, with moderate amount of radiotracer in the bladder.
The gallbladder surgically absent.
The abdominal aorta is normal in caliber.
IMPRESSION:
1. PSMA positive disease in the prostate gland consistent with local recurrence, and within bilateral iliac, and a small distal retroperitoneal lymph nodes, consistent with nodal metastases.
2. Mild focal uptake in a right sixth rib sclerotic lesion is indeterminate, may reflect a benign fibro-osseous lesion however metastasis is difficult to exclude. Prior imaging if available may be helpful for comparison to ensure stability; if no priors are available, consider follow-up.
Thanks for the detail on the report. It seems we are in alignment in suggesting not to think it futile to treat all the LN Mets, whole pelvis extended and prostate. Not diverted because of the equivocal rib finding. Certainly short term ADT will be of value to support the efficacy. And often it has been started a couple of months before the RT. But a recent trial suggests that starting it at the same time as the RT )with Lupron or similar) and NOT adding bicalutamide may provide a therapeutic extra benefit by stimulating the cancer with the androgen flare right as RT is started.
I’m traveling now but will try to find the link for you to discuss with your team.
You may be right, but my urologist on the front end said Firmagan had more SEs than Lupron. He proposed starting on Firmagan and switching to Lupron after a month or so. I ultimately saw an MO and started on bicalutamide, then added Lupron three weeks later, then dropped bicalutamide three weeks after that.
"There seems to be indication that Zytiga causes early hormone resistance. We are a bit concerned."
That is not the case - the opposite is true. Zytiga extends the time until hormone resistance occurs.
" If it's a combination of Lupron + Zytiga, do you take them simultaneously or do you take Lupron for 1 or 2 months or 3 months and then add Zytiga? What dosage each?"
You have to take them both together. Lupron is usually a 3,4 or 6-month shot. Abiraterone is taken as 1000 mg on an empty stomach. Also, he has to be take5 mg prednisone (with food).
Thanks for your reply. There are 5 areas of disease that show up in PSMA scan. For detailed findings, please see my reply to MateoBeach above. One uptake in prostate, two lymph nodes in pelvic and one cluster slightly above pelvis (but RO seems to regard it as if it's in pelvis and is able to target it), one in 6th rib (One RO think it's mets but another RO is not sure).
You mentioned "Zytiga extends the time until hormone resistance occurs". Can you forward a link of the study on this?
Also, is there any difference when to do radiation? Radiation first and then hormone therapy? or simultaneaously with hormone therapy? or hormone therapy for 3 -6 months first and then radiation? It's a theoretical question as we are probably unable to schedule radiation quickly.
For now, I think it's useful to consider the low rib uptake to be a false positive. It seems to be common in solitary rib spots. The uptake in the prostate apex may be from urinary excretion, but why not treat it?
I hope you consider that clinical trial. It seems tailor-made for his situation.
Hormone therapy usually starts a couple of months before radiation. It halts all progression, so it will give you time to investigate.
What has been advised re local prostate recurrence? He has already had prostate radiation.....local treatment with brachytherapy, or something else??? Another prostate biopsy to try to confirm that uptake is not false positive?
Thanks for your reply and the link. There are 5 areas of disease that show up in PSMA scan. For detailed findings, please see my reply to MateoBeach above. One uptake in prostate, two lymph nodes in pelvic and one cluster slightly above pelvis (but RO seems to regard it as if it's in pelvis and is able to target it), one in 6th rib (One RO think it's mets but another RO is not sure).
Lupron and Zytiga combined well for me. You want to optimally assist the radiation, and this will do it. Great recent studies as you can see.
He needs plenty of cardiovascular and weight bearing exercise if he’s not getting it already. Dramatically improves every aspect of treatment efficacy and quality of life.
Bills met was found in 2015 when PSA didn’t go below 3 after surgery by c11 choline pet scan at Mayo Rochester. Was found in pelvic lymphs at surg that hadn’t showed up on pre surgical MRI. Pet scan found in lymph around ? T3. Started with chemo, then 6 mo of zytiga, Lupron, prednisone, then 37 radiation and the same meds, then the same meds for a year. He was taking 1000 mg and 10 mg prednisone. He was non detectable and no evidence of disease 6 years no cancer meds or treatment the last 5 years. His standard PSA has remained < 0.1.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Suggested MDs for Second Opinions? BCR (recurrence) after primary surgery and adjuvant radiation and ADT w/Zytiga
Back to ADT
Crossroads - ADT or wait for psma pet/LU 177? Meeting with oncologist to discuss tomorrow 
PSA vs PSMA
Raising PSA now 0.20 - Next Move?
